OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's Disease
Dana Brinker, Katarzyna Śmiłowska, Steffen Paschen, et al.
Movement Disorders Clinical Practice (2023) Vol. 11, Iss. 3, pp. 209-219
Open Access | Times Cited: 7
Dana Brinker, Katarzyna Śmiłowska, Steffen Paschen, et al.
Movement Disorders Clinical Practice (2023) Vol. 11, Iss. 3, pp. 209-219
Open Access | Times Cited: 7
Showing 7 citing articles:
Subcutaneous Levodopa: A New Engine for the Vintage Molecule
Karolina Popławska-Domaszewicz, Lucia Batzu, Cristian Falup‐Pecurariu, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 1055-1068
Open Access | Times Cited: 7
Karolina Popławska-Domaszewicz, Lucia Batzu, Cristian Falup‐Pecurariu, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 1055-1068
Open Access | Times Cited: 7
Advanced therapies in Parkinson’s disease: an individualized approach to their indication
Nils Schröter, Bastian Sajonz, Wolfgang H. Jost, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 11, pp. 1285-1293
Open Access | Times Cited: 5
Nils Schröter, Bastian Sajonz, Wolfgang H. Jost, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 11, pp. 1285-1293
Open Access | Times Cited: 5
Managing cognitive impairment in Parkinson’s disease: an update of the literature
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson’s Disease
Hannah A. Blair
CNS Drugs (2025)
Closed Access
Hannah A. Blair
CNS Drugs (2025)
Closed Access
Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”
Angelo Antonini, К. Ray Chaudhuri, Josefa Domingos, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Angelo Antonini, К. Ray Chaudhuri, Josefa Domingos, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Gender disparity in access to advanced therapies for patients with Parkinson’s disease: a retrospective real-word study
G. Maccarrone, Gennaro Saporito, Patrizia Sucapane, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
G. Maccarrone, Gennaro Saporito, Patrizia Sucapane, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Satisfaction and Preferences for Infusion Therapies in Advanced Parkinson’s Disease—Patient Perspective
Julia Węgrzynek-Gallina, Tomasz Chmiela, Michał Borończyk, et al.
Medicina (2024) Vol. 61, Iss. 1, pp. 27-27
Open Access
Julia Węgrzynek-Gallina, Tomasz Chmiela, Michał Borończyk, et al.
Medicina (2024) Vol. 61, Iss. 1, pp. 27-27
Open Access
